117 related articles for article (PubMed ID: 16008658)
1. Abdominal wall ulceration and mucinosis secondary to recombinant human interferon-beta-1b.
Wells J; Kossard S; McGrath M
Australas J Dermatol; 2005 Aug; 46(3):202-4. PubMed ID: 16008658
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous mucinoses complicating interferon beta-1b therapy.
Benito-León J; Borbujo J; Cortés L
Eur Neurol; 2002; 47(2):123-4. PubMed ID: 11844903
[No Abstract] [Full Text] [Related]
3. Severe local skin reactions to interferon beta-1b in multiple sclerosis-improvement by deep subcutaneous injection.
Nakamura Y; Kawachi Y; Furuta J; Otsuka F
Eur J Dermatol; 2008; 18(5):579-82. PubMed ID: 18693165
[TBL] [Abstract][Full Text] [Related]
4. Lobular panniculitis at the site of subcutaneous interferon beta injections for the treatment of multiple sclerosis can histologically mimic pancreatic panniculitis. A study of 12 cases.
Ball NJ; Cowan BJ; Hashimoto SA
J Cutan Pathol; 2009 Mar; 36(3):331-7. PubMed ID: 19032383
[TBL] [Abstract][Full Text] [Related]
5. Fixed drug eruption with interferon-beta-1b.
Tai YJ; Tam M
Australas J Dermatol; 2005 Aug; 46(3):154-7. PubMed ID: 16008645
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous necrosis associated with recombinant interferon injection.
Weinberg JM
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):807-8. PubMed ID: 9810903
[No Abstract] [Full Text] [Related]
7. Necrotizing cutaneous lesions caused by interferon beta injections in a patient with multiple sclerosis.
Feldmann R; Löw-Weiser H; Duschet P; Gschnait F
Dermatology; 1997; 195(1):52-3. PubMed ID: 9267740
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous necrosis associated with recombinant interferon injection. Report of three cases with interferon beta-1b and review of the literature.
Weinberg JM; Wolfe JT; Sood S; Saruk M; Rook AH; Spiers EM
Acta Derm Venereol; 1997 Mar; 77(2):146-8. PubMed ID: 9111829
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis.
Webster GF; Knobler RL; Lublin FD; Kramer EM; Hochman LR
J Am Acad Dermatol; 1996 Feb; 34(2 Pt 2):365-7. PubMed ID: 8655728
[TBL] [Abstract][Full Text] [Related]
10. Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient.
Heinzerling L; Dummer R; Burg G; Schmid-Grendelmeier P
Eur J Dermatol; 2002; 12(2):194-7. PubMed ID: 11872423
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of danaparoid compared with enoxaparin as deep vein thrombosis prophylaxis after hip replacement surgery.
Wade WE
Am J Orthop (Belle Mead NJ); 1999 Apr; 28(4):229-31. PubMed ID: 10220094
[TBL] [Abstract][Full Text] [Related]
12. [Interferons beta in patients with multiple sclerosis].
Vlasov IaV; Kuznetsova NI; Poverennova IE; Khivintseva EV
Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(7):54-5. PubMed ID: 16117149
[No Abstract] [Full Text] [Related]
13. Cutaneous reactions to recombinant human interferon beta-1b: the clinical and histologic spectrum.
Elgart GW; Sheremata W; Ahn YS
J Am Acad Dermatol; 1997 Oct; 37(4):553-8. PubMed ID: 9344192
[TBL] [Abstract][Full Text] [Related]
14. Necrotizing skin lesions and NABs development in a multiple sclerosis patient treated with IFNbeta 1b.
Casoni F; Merelli E; Bedin R; Martella A; Cesinaro A; Bertolotto A
Mult Scler; 2003 Aug; 9(4):420-3. PubMed ID: 12926849
[TBL] [Abstract][Full Text] [Related]
15. Interferon beta-induced panniculitis mimicking acute appendicitis.
Poulin F; Rico P; Côté J; Bégin LR
Arch Dermatol; 2009 Aug; 145(8):916-7. PubMed ID: 19687423
[TBL] [Abstract][Full Text] [Related]
16. Optimization of the safety and efficacy of interferon beta 1b and azathioprine combination therapy in multiple sclerosis.
Pulicken M; Bash CN; Costello K; Said A; Cuffari C; Wilterdink JL; Rogg JM; Mills P; Calabresi PA
Mult Scler; 2005 Apr; 11(2):169-74. PubMed ID: 15794390
[TBL] [Abstract][Full Text] [Related]
17. Local reactions associated with subcutaneous injections of both beta-interferon 1a and 1b.
García-F-Villalta M; Daudén E; Sánchez J; Fraga J; Ramo C; García-Díez A
Acta Derm Venereol; 2001 May; 81(2):152. PubMed ID: 11501663
[No Abstract] [Full Text] [Related]
18. Severe liver dysfunction possibly caused by the combination of interferon beta-1b therapy and melilot (sweet clover) supplement.
Tamura S; Warabi Y; Matsubara S
J Clin Pharm Ther; 2012 Dec; 37(6):724-5. PubMed ID: 22642738
[TBL] [Abstract][Full Text] [Related]
19. Panniculitis and lipoatrophy after subcutaneous injection of interferon beta-1b in a patient with multiple sclerosis.
O'Sullivan SS; Cronin EM; Sweeney BJ; Bourke JF; Fitzgibbon J
J Neurol Neurosurg Psychiatry; 2006 Dec; 77(12):1382-3. PubMed ID: 16782776
[No Abstract] [Full Text] [Related]
20. [The first experience of the use the Russian Β-interferon-1b biosimilar (infibeta) in the daily practice of the Moscow Center of Multiple Sclerosis].
Popova EV; Boĭko AN; Davydovskaia MV; Demina TL; Kukel' TM; Lashch NIu; Popova NF; Khachanova NV; Shchur SG; Gusev EI
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(10 Pt 2):93-6. PubMed ID: 24300821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
